Brief: Venus Medtech Hangzhou Says Athena Medtech To Buy Mitraltech
08/12/2021 01:12
Dec 8 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK :
* ATHENA MEDTECH TO BUY ALL ISSUED, OUTSTANDING SHARES OF
MITRALTECH
* AGGREGATE CLOSING CONSIDERATION FOR DEAL US$150 MILLION
* DEAL MAY INCLUDE EARN-OUT CONSIDERATION NOT EXCEEDING
US$116
MILLION
Source text for Eikon: ID:nHKS72XvhC
Further company coverage: 2500.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market